Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Results of a double-blind clinical trial.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  American Journal of Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9343(85)90454-1PMID 3917606
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Measurement of urinary histamine: comparison of fluorometric and radioisotopic-enzymatic assay procedures.

  1983cited by this paper
• Cimetidine: II. Adverse reactions and patterns of use.

  1982cited by this paper
• Measurement of plasma histamine: description of an improved method and normal values.

  1982cited by this paper
• Urticaria pigmentosa: clinical picture and response to oral disodium cromoglycate

  1981cited by this paper
• Oral disodium cromoglycate in mastocytosis.

  1981cited by this paper
• Measurement of urinary histamine: development of methodology and normal values.

  1981cited by this paper
• Cytobiological and Clinical Aspects of Tissue Mast Cell Leukaemia

  1980cited by this paper
• The effect of cimetidine and propantheline on the symptoms of a patient with systemic mastocytosis.

  1980cited by this paper
• Treatment of systemic mastocytosis.

  1980cited by this paper
• Combination H1 and H2 Receptor Antagonist Therapy in Mastocytosis

  1980cited by this paper
• Treatment of systemic mastocytosis.

  1980cited by this paper
• Malabsorption and gastric hyperacidity in systemic mastocytosis. Results of cimetidine therapy.

  1980cited by this paper
• Urticaria pigmentosa: treatment with cimetidine and chlorpheniramine.

  1979cited by this paper
• Effect of cimetidine on gastric hypersecretion and diarrhea in systemic mastocytosis.

  1979cited by this paper
• Oral disodium cromoglycate in the treatment of systemic mastocytosis.

  1979cited by this paper
• An approach to immunotherapy using antibody to IgE in mast cell leukemia

  1976cited by this paper
• Systemic mastocytosis: control of lifelong diarrhea by ingested disodium cromoglycate.

  1974cited by this paper
• Dermatology in general medicine

  1971cited by this paper
• Mastocytosis Syndrome.

  1964cited by this paper

• The evaluation, management, and future of indolent systemic mastocytosis

  2025cites this paper
• Mast Cell–Targeting Therapies in Mast Cell Activation Syndromes

  2024cites this paper
• The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome.

  2020cites this paper
• Paediatric Mastocytosis

  2019cites this paper
• Hereditary Alpha Tryptasemia: Genotyping and Associated Clinical Features.

  2018cites this paper
• Pharmacotherapy of mast cell disorders

  2017cites this paper
• Systemic mastocytosis with KIT V560G mutation presenting as recurrent episodes of vascular collapse: response to disodium cromoglycate and disease outcome

  2017cites this paper
• A Study on Clinical Profile of Childhood Asthma and Its Comorbidities

  2017cites this paper
• Pathogenesis and Pathology of Mastocytosis.

  2017cites this paper
• Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease

  2016cites this paper
• Mastocytosis in Children: What to Do?

  2016cites this paper
• Mast Cell Activation Syndromes

  2016cites this paper
• Pharmacological treatment options for mast cell activation disease

  2016cites this paper
• Mast Cell Activation

  2016cites this paper
• Response of patients with indolent systemic mastocytosis to tamoxifen citrate.

  2016cites this paper
• H1‐antihistamines for primary mast cell activation syndromes: a systematic review

  2015influential citation
• Diagnosis and Treatment of Anaphylaxis in Patients with Mastocytosis

  2014cites this paper
• Occupational Contact Dermatitis Due to Acrylates and Methacrylates

  2014cites this paper
• Mastocytosis: update on pharmacotherapy and future directions

  2013cites this paper
• Mast Cell Activation Syndrome: A Review

  2013cites this paper
• Rupatadine improves quality of life in mastocytosis: a randomized, double‐blind, placebo‐controlled trial

  2013cites this paper
• Immunology and Clinical Manifestations of Non-Clonal Mast Cell Activation Syndrome

  2013cites this paper
• Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes.

  2013cites this paper
• New insights into the pathogenesis, diagnosis, and management of mastocytosis.

  2012cites this paper
• Anaphylaxis in Mastocytosis

  2011cites this paper
• Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations.

  2011cites this paper
• Chapter 16 Anaphylaxis in Mastocytosis

  2011cites this paper
• Guidelines for the Diagnosis and Treatment of Cutaneous Mastocytosis in Children

  2011cites this paper
• Oral and inhaled sodium cromoglicate in the management of systemic mastocytosis: a case report

  2010cites this paper
• Systemic mastocytosis in association with plasma cell dyscrasias: report of a case and review of the literature.

  2009cites this paper
• KIT and Mastocytosis

  2008cites this paper
• Response by J. M. Brown, T. M. Wilson and D. D. Metcalfe

  2008cites this paper
• How we diagnose and treat WHO-defined systemic mastocytosis in adults

  2008cites this paper
• Pathogenesis, clinical features, and treatment advances in mastocytosis.

  2006cites this paper
• Treatment of systemic mastocytosis.

  2006cites this paper
• Systemic mastocytosis: current classification and novel therapeutic options.

  2006cites this paper
• Atypical myeloproliferative disorders: diagnosis and management.

  2006cites this paper
• Mastocitosis del adulto. Descripcin de 9 casos clinicopatolgicos

  2005cites this paper
• [Mastocytosis in adults. Description of nine clinicopathological cases].

  2005cites this paper
• Disorders of flushing

  2005cites this paper
• Mastozytosen ± Diagnostik, Klassifikation, Therapie, aktuelle pathophysiologische Ansätze

  2005cites this paper
• The role of mast cells in common gastrointestinal diseases

  2004cites this paper
• Clinical, genetic, and therapeutic insights into systemic mast cell disease

  2004cites this paper
• Urticaria pigmentosa.

  2004cites this paper
• [Treatment of systemic mastocytosis].

  2003cites this paper
• Traitement des mastocytoses systémiques

  2003cites this paper
• Neuroimmunology and inflammation: implications for therapy of allergic and autoimmune diseases.

  2003cites this paper
• Diagnosis and treatment of systemic mastocytosis: state of the art

  2003cites this paper
• Mastocytosis in Childhood

  2002cites this paper
• Mastocytosis: current concepts in diagnosis and treatment

  2002cites this paper
• Mastocytosis.

  2001cites this paper
• Treatment of mastocytosis: pharmacologic basis and current concepts.

  2001cites this paper
• Mastocytosis and the skin.

  2000cites this paper
• Treatment of systemic mast cell disorders.

  2000cites this paper
• Unapproved dermatologic indications for H2 receptor antagonists, cromolyn sodium, and ketotifen.

  2000cites this paper
• Gastrointestinal abnormalities and involvement in systemic mastocytosis.

  2000cites this paper
• Unexplained loss of consciousness: Systemic mastocytosis

  2000cites this paper
• Antigen-specific anti-allergic inflammatory effects of sodium cromoglycate. Is there a new cellular mechanism?

  1999cites this paper
• SYSTEMIC MASTOCYTOSIS AND OTHER MAST CELL NEOPLASMS

  1999cites this paper
• Cutaneous and systemic manifestations of mastocytosis.

  1999cites this paper
• Cutaneous mastocytosis in adults. evaluation of 14 patients with respect to systemic disease manifestations.

  1998cites this paper
• Systemic mastocytosis presenting as profound cardiovascular collapse during anaesthesia

  1998cites this paper
• Cutaneous Mastocytosis in Adults

  1998cites this paper
• Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis.

  1997cites this paper
• Mastocytosis presenting as a skeletal disorder.

  1996cites this paper
• Long‐term follow‐up of indolent mastocytosis in adults

  1996cites this paper
• Secretory diarrhea in children: newly recognized toxins and hormone-secreting tumors.

  1996cites this paper
• The mast cell and mast cell disease.

  1995cites this paper
• URTICARIA PIGMENTOSA

  1995cites this paper
• Biology, diagnosis and therapy of mastocytosis.

  1995cites this paper
• Clinical advances in mastocytosis

  1995cites this paper
• Southwestern Internal Medicine Conference: mastocytosis: developments during the past decade.

  1995cites this paper
• Systemic mastocytosis: a diagnostic challenge.

  1995cites this paper
• Comparison of azelastine and chlorpheniramine in the treatment of mastocytosis.

  1993cites this paper
• Chronic steroid-resistant urticaria.

  1993cites this paper
• Systemic sclerosis. The role of the mast cell and cytokines.

  1992cites this paper
• Acute nonlymphocytic leukemia in systemic mastocytosis with biclonal gammopathy.

  1992cites this paper
• [Systemic mastocytosis].

  1992cites this paper
• Radiation Therapy in a Case of Systemic Mastocytosis: Evaluation of Histamine Levels and Mucosal Effects

  1992cites this paper
• The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure.

  1992cites this paper
• Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection.

  1992cites this paper
• The skin in mastocytosis.

  1991cites this paper
• Systemic mast cell disease: a review of the literature with special focus on the gastrointestinal manifestations.

  1991cites this paper
• A case of systemic mastocytosis; therapeutic efficacy of ketotifen

  1991cites this paper
• Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital.

  1991cites this paper
• Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital.

  1991cites this paper
• The skin in mastocytosis.

  1991cites this paper
• Effects of tixocortol pivalate on gastrointestinal disease in systemic mastocytosis: a preliminary study

  1991cites this paper
• Diffuse Cutaneous Mastocytosis Mimicking Staphylococcal Scalded‐Skin Syndrome: Report of Three Cases

  1991cites this paper
• TUMOROUS NODULES ON THE LOWER EXTREMITIES

  1991cites this paper
• Lymphadenopathic mastocytosis with eosinophilia and biclonal gammopathy.

  1990cites this paper
• Newer aspects of urticaria pigmentosa.

  1990cites this paper
• [Systemic mastocytosis. Polymorphism of bone involvement. Report of 3 cases 2 of which with diffuse osteocondensation].

  1990cites this paper
• Cromolyn sodium in the management of systemic mastocytosis.

  1990cites this paper
• Urticaria pigmentosa: an anesthetic challenge.

  1990cites this paper
• Massive histamine release in a patient with systemic mastocytosis.

  1990cites this paper
• [The clinical spectrum of mastocytosis].

  1990cites this paper
• Fever, hemorrhagic bullae and gastritis in a 20-month-old male.

  1989cites this paper
• Analysis of the wheal-and-flare reactions that follow the intradermal injection of histamine and morphine in adults with recurrent, unexplained anaphylaxis and systemic mastocytosis.

  1989cites this paper
• Inotropic effect of nicardipine in patients with heart failure: assessment by left ventricular end-systolic pressure-volume analysis.

  1989cites this paper